
Certara Investor Relations Material
Latest events

Q1 2025
Certara
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Certara Inc
Access all reports
Certara Inc. is a life sciences technology company that provides software and services to accelerate drug development and regulatory approval processes. The company specializes in biosimulation, a technology that uses virtual models to predict how drugs behave in the human body, helping pharmaceutical companies optimize clinical trials and drug development strategies. Certara’s offerings support decision-making throughout the drug development lifecycle, from discovery through post-market stages, across a range of therapeutic areas. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Certara Inc


Q1 2025
Certara Inc


45th Annual William Blair Growth Stock Conference
Certara Inc
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
CERT
Country
🇺🇸 United States